Immunotherapy Shows Promise as Alzheimer’s Treatment

Summary: Researchers unveiled a novel approach to combat Alzheimer’s disease by activating microglia, the brain’s immune cells, to devour amyloid beta plaques, a hallmark of the condition. This study highlights…

Compound May Curb Alcohol Dependence

Summary: The compound LY2444296, which blocks the kappa opioid receptor, significantly reduces alcohol consumption in animal models of alcohol dependence. This study suggests LY2444296 could be a breakthrough in treating…

CaMKII Can Be Regulated to Mitigate Alzheimer’s

Summary: The CaMKII protein, critical in brain and heart function, can be regulated to mitigate Alzheimer’s and heart conditions using three types of drug inhibitors. Their findings reveal that these…

Long-term Acid Reflux Drugs Linked to Higher Dementia Risk?

Summary: Long-term use (over 4.4 years) of proton pump inhibitors, prescribed for acid reflux, may be associated with an increased risk of dementia. However, this research does not establish a…

Glutamate Receptor Activation: A Potential Cure for Opioid Addiction?

Summary: Scientists discovered a potential new weapon in the battle against opioid use disorder (OUD), a condition that affects over two million people in the U.S. alone. The drug, ADX106772,…